Mark J. Vignola, Chief Financial Officer at Terns Pharmaceuticals, Inc. (TERN), bought 4,791 shares at $4.44 ($21K) on 2024-05-31, disclosed to the SEC on 2024-06-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TERN | BUY | 2023-12-04 | $3K | — | Filing → |
| TERN | BUY | 2023-06-02 | $14K | — | Filing → |
| TERN | BUY | 2023-02-03 | $4 | — | Filing → |